⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NUVB News
Nuvation Bio Inc.
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
prnewswire.com
NUVB
Nuvation Bio to Participate in Upcoming Investor Conferences
businesswire.com
NUVB
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
businesswire.com
NUVB
Nuvation Bio to Participate in Upcoming Investor Conferences
businesswire.com
NUVB
NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street
prnewswire.com
ESRT
NUVB
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer
businesswire.com
NUVB
Nuvation Bio Receives Approval from Japan’s Ministry of Health, Labour and Welfare for IBTROZI TM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer
businesswire.com
NUVB
Nuvation Bio Announces New Data from Pivotal Clinical Studies of IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at 2025 World Conference on Lung Cancer
businesswire.com
NUVB